Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 10, 2023

SELL
$11.12 - $22.2 $5,582 - $11,144
-502 Reduced 2.99%
16,314 $186,000
Q4 2022

Jan 17, 2023

BUY
$18.12 - $27.32 $304,705 - $459,413
16,816 New
16,816 $0
Q1 2022

Apr 11, 2022

BUY
$14.54 - $21.5 $4,536 - $6,708
312 Added 2.21%
14,452 $261,000
Q3 2021

Oct 29, 2021

BUY
$26.01 - $38.22 $367,781 - $540,430
14,140 New
14,140 $453,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $300M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.